Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of PXR Activation on Blood Pressure
NCT01690104Phase 4Completed
- Sponsor
- University of Oulu
- Start
- Aug 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rifampicin in hypertension (HTN), sponsored by University of Oulu. Started Aug 2012; status: completed.
02
Drugs
rifampicin
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01690104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01690104.